• Viral infections

Ebanga Generic Name & Formulations

General Description

Ansuvimab-zykl 400mg; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; preservative-free.

Pharmacological Class

Human IgG1 monoclonal antibody.

How Supplied

Single-dose vials—1, 4, 8, 36

Generic Availability


Ebanga Indications


Infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection.

Limitations of Use

Not established for other species of the Ebolavirus and Marburgvirus genera.

Ebanga Dosage and Administration

Adults and Children

See full labeling. Give 50mg/kg as a single IV infusion over 60mins.

Ebanga Contraindications

Not Applicable

Ebanga Boxed Warnings

Not Applicable

Ebanga Warnings/Precautions


Monitor for hypersensitivity reactions including infusion-associated events. Discontinue immediately and treat if severe or life-threatening hypersensitivity reactions occur. Pregnancy (do not withhold treatment). Nursing mothers.

Ebanga Pharmacokinetics

See Literature

Ebanga Interactions


Avoid concomitant live vaccines.

Ebanga Adverse Reactions

Adverse Reactions

Pyrexia, tachycardia, diarrhea, vomiting, hypotension, tachypnea, chills.

Ebanga Clinical Trials

See Literature

Ebanga Note

Not Applicable

Ebanga Patient Counseling

See Literature